1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow HxB2.WT.Core-C4b: new trials by email Literature Review of HxB2.WT.Core-C4b trials Research Report on HxB2.WT.Core-C4b
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health 426c.Mod.Core-C4b, HxB2.WT.Core-C4b, 3M-052-AF adjuvant - HIV | Phase 1 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 42 | 2025-03-17 | 2025-09-25 |
HIV Infections (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)